ACS Endorses Routine PSA Screening; PCEC Pushes for Earlier Risk Assessment
A recent article by Howard Wolinsky examines the American Cancer Society's updated PSA screening recommendations and highlights the Prostate Cancer Education Council's advocacy for earlier, individualized prostate cancer risk assessment.
Source: Howard Wolinsky | November 2026
PCEC Responds to the American Cancer Society's 2026 Prostate Cancer Screening Guidelines
While PCEC supports many of the updated recommendations, we continue to advocate for earlier baseline PSA testing, beginning at age 45 for men at average risk and age 40 for Black men and others at higher risk.
Our official position statement outlines where our recommendations align with the ACS guideline, where we differ, and why expanding access to early detection remains essential.
Our official position statement outlines where our recommendations align with the ACS guideline, where we differ, and why expanding access to early detection remains essential.
Beyond the Diagnosis: John Elway & Michael Michalski on Resilience, Friendship, and Hope
Featuring: John Elway and Michalski
Every prostate cancer journey is different. No one should face it without information, encouragement, and support.
PCEC is committed to empowering men and their families through prostate health education, early detection, and access to trusted resources.
Special Thank you to Dr. Crawford and Ground Rounds in Urology.
The role of Robotic Assisted Surgery in your Prostate Cancer Journey
Featuring:
Garrett Pohlman, M.D.
Kearney Urology Center, PC
Kearney, Nebraska
Promise. In the fight against prostate cancer, your DNA may be the most powerful tool
Featuring:
Genetic Counselor, Justin Lorentz
Odette Cancer Center, Sunny Brook Health Center
Toronto, Canada
Blue Ribbon Prostate Talks: Understanding PSMA PET Scans
Featuring:
Brigette Serfaty, M.S., Pharm.D., BCNP, FAPhA, Dip-ACLM
Special Thank you to Telix Pharmaceuticals for helping make this type of valuable education possible!